| ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ... Cancer research 75 (20), 4364-4371, 2015 | 81 | 2015 |
| The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin Z Varasteh, U Rosenström, I Velikyan, B Mitran, M Altai, H Honarvar, ... Molecules 19 (7), 10455-10472, 2014 | 75 | 2014 |
| HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled … C Hofström, M Altai, H Honarvar, J Strand, J Malmberg, ... Journal of medicinal chemistry 56 (12), 4966-4974, 2013 | 71 | 2013 |
| Feasibility of affibody molecule-based PNA-mediated radionuclide pretargeting of malignant tumors H Honarvar, K Westerlund, M Altai, M Sandström, A Orlova, V Tolmachev, ... Theranostics 6 (1), 93, 2016 | 66 | 2016 |
| Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591 V Tolmachev, Z Varasteh, H Honarvar, SJ Hosseinimehr, O Eriksson, ... Journal of Nuclear Medicine 55 (2), 294-300, 2014 | 63 | 2014 |
| Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts J Strand, H Honarvar, A Perols, A Orlova, RK Selvaraju, AE Karlström, ... PLoS One 8 (8), e70028, 2013 | 59 | 2013 |
| Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule A Orlova, M Malm, M Rosestedt, Z Varasteh, K Andersson, RK Selvaraju, ... European journal of nuclear medicine and molecular imaging 41, 1450-1459, 2014 | 56 | 2014 |
| Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins S Lindbo, J Garousi, M Åstrand, H Honarvar, A Orlova, S Hober, ... Bioconjugate chemistry 27 (3), 716-726, 2016 | 54 | 2016 |
| Feasibility of affibody-based bioorthogonal chemistry–mediated radionuclide pretargeting M Altai, A Perols, M Tsourma, B Mitran, H Honarvar, M Robillard, ... Journal of Nuclear Medicine 57 (3), 431-436, 2016 | 53 | 2016 |
| Increasing the net negative charge by replacement of DOTA chelator with DOTAGA improves the biodistribution of radiolabeled second-generation synthetic affibody molecules K Westerlund, H Honarvar, E Norrstrom, J Strand, B Mitran, A Orlova, ... Molecular pharmaceutics 13 (5), 1668-1678, 2016 | 44 | 2016 |
| Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules A Perols, H Honarvar, J Strand, R Selvaraju, A Orlova, ... Bioconjugate chemistry 23 (8), 1661-1670, 2012 | 43 | 2012 |
| Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ... Molecular pharmaceutics 13 (11), 3676-3687, 2016 | 41 | 2016 |
| Design, preparation, and characterization of PNA-based hybridization probes for affibody-molecule-mediated pretargeting K Westerlund, H Honarvar, V Tolmachev, A Eriksson Karlström Bioconjugate chemistry 26 (8), 1724-1736, 2015 | 40 | 2015 |
| Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 affibody molecule H HONARvAR, J Garousi, E Gunneriusson, I HöIDéN-GUTHENbERG, ... International journal of oncology 46 (2), 513-520, 2015 | 34 | 2015 |
| Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors H Honarvar, C Müller, S Cohrs, S Haller, K Westerlund, AE Karlström, ... Nuclear medicine and biology 45, 15-21, 2017 | 33 | 2017 |
| Incorporation of a Triglutamyl Spacer Improves the Biodistribution of Synthetic Affibody Molecules Radiofluorinated at the N-Terminus via Oxime Formation with 18F … D Rosik, A Thibblin, G Antoni, H Honarvar, J Strand, RK Selvaraju, M Altai, ... Bioconjugate chemistry 25 (1), 82-92, 2014 | 32 | 2014 |
| Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe H Honarvar, E Calce, N Doti, E Langella, A Orlova, J Buijs, V D’Amato, ... Scientific Reports 8 (1), 2998, 2018 | 29 | 2018 |
| 188Re-ZHER2: V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment M Altai, H Wållberg, H Honarvar, J Strand, A Orlova, Z Varasteh, ... Journal of Nuclear Medicine 55 (11), 1842-1848, 2014 | 29 | 2014 |
| Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: development of an optimized conjugation protocol and 177Lu labeling M Altai, K Westerlund, J Velletta, B Mitran, H Honarvar, AE Karlström Nuclear Medicine and Biology 54, 1-9, 2017 | 27 | 2017 |
| Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re M Altai, H Honarvar, H Wållberg, J Strand, Z Varasteh, M Rosestedt, ... European Journal of Medicinal Chemistry 87, 519-528, 2014 | 26 | 2014 |
